menu
    • menu

    Company profile for MediWound

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MediWound Ltd. is a biotechnology niche specialty company. Established in 2001, MediWound is focused on developing, manufacturing and globally commercializing innovative products that address unmet needs in the fields of severe burn and chronic wound management. MediWound’s goal is to provide healthcare professionals and patients with its innovative, burn wound eschar removal agent, NexoBrid™. NexoBrid™, is indicated in ...
    MediWound Ltd. is a biotechnology niche specialty company. Established in 2001, MediWound is focused on developing, manufacturing and globally commercializing innovative products that address unmet needs in the fields of severe burn and chronic wound management. MediWound’s goal is to provide healthcare professionals and patients with its innovative, burn wound eschar removal agent, NexoBrid™. NexoBrid™, is indicated in Europe for removal of eschar in adults with deep partial- and full-thickness thermal burns. NexoBrid™ successfully completed clinical development in hospitalized burn wounds and was launched throughout Europe.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MediWoundIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    42 Hayarkon Street, Yavne
    Telephone
    Telephone
    +972 77 9714100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mediwound.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/mediwound
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MediWound Data: NexoBrid Prevents Traumatic Tattoos
    MediWound Data: NexoBrid Prevents Traumatic Tattoos

    10 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/10/3203047/30505/en/MediWound-Reports-New-Clinical-Data-Demonstrating-NexoBrid-s-Effectiveness-in-Preventing-Traumatic-Tattoos-After-Abrasion-and-Blast-Injuries.html

    GLOBENEWSWIRE
    10 Dec 2025
    Share Share
    Mediwound Unveils Q3 2025 Financials And Corporate Update
    Mediwound Unveils Q3 2025 Financials And Corporate Update

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191754/30505/en/MediWound-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Mediwound To Report Third Quarter 2025 Financial Results
    Mediwound To Report Third Quarter 2025 Financial Results

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181346/30505/en/MediWound-to-Report-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Mediwound Completes Expansion Of GMP Facility For Nexobrid
    Mediwound Completes Expansion Of GMP Facility For Nexobrid

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179186/30505/en/MediWound-Successfully-Completes-Commissioning-of-Expanded-GMP-Manufacturing-Facility-for-NexoBrid.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Mediwound Launches $30M Registered Direct Share Offering
    Mediwound Launches $30M Registered Direct Share Offering

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3157737/30505/en/MediWound-Announces-30-Million-Registered-Direct-Offering-of-Ordinary-Shares.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Mediwound Expands Global Reach With Nexobrid® Marketing Approval
    Mediwound Expands Global Reach With Nexobrid® Marketing Approval

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3156180/30505/en/MediWound-Expands-Global-Reach-with-Marketing-Approval-of-NexoBrid-in-Australia.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search